Bodenrader Mark - Insider Non-Derivative Transactions at Cerevel Therapeutics Holdings, Inc. (CERE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 1, 2024, Bodenrader Mark's relationship to Cerevel Therapeutics Holdings, Inc. (CERE) is Officer (See Remarks), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CERE insiders.

Data Source: SEC.
Bodenrader Mark - Insider Non-Derivative Transactions of CERE Common Stock
Bodenrader Mark - Insider Non-Derivative Transactions at CERE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 2, 2024 Disposition -- (Common Stock) 17724 0 0
Dec 21, 2023 Sell -- (Common Stock) 7889 41.42 17724
Dec 20, 2023 M -- (Common Stock) 14199 0 20528
Dec 20, 2023 M -- (Common Stock) 5085 0 25613
Jun 3, 2023 Sell -- (Common Stock) 1895 32.95 5522
Jun 2, 2023 M -- (Common Stock) 4733 0 7417